CSIMarket



Johnson and Johnson  (JNJ)
Other Ticker:  
 
 

JNJ's EPS from Cont. Operations Growth by Quarter and Year

Johnson And Johnson's EPS from Cont. Operations results by quarter and year




JNJ EPS from Cont. Operations (in $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter January - 1.81 0.66 1.52
III Quarter October - 1.39 1.35 0.67
II Quarter July - 2.38 1.38 2.11
I Quarter April 1.96 2.35 2.20 1.41
FY   1.96 7.93 5.59 5.71



JNJ EPS from Cont. Operations first quarter 2022 Y/Y Growth Comment
Johnson And Johnson reported decline in EPS from Cont. Operations in the first quarter 2022 by -16.6% to $ 1.96 , from the same quarter in 2021.
The contraction in the first quarter 2022 Johnson And Johnson's EPS from Cont. Operations compares unfavorably to the Company's average EPS from Cont. Operations increase of 14.86%.

Among companies who have reported first quarter 2022 results in the Major Pharmaceutical Preparations industry only one Company has achieved higher year on year EPS from Cont. Operations results in the first quarter 2022. While Johnson And Johnson' s EPS from Cont. Operations fall of -16.6% ranks overall at the positon no. 374 in the first quarter 2022.




JNJ EPS from Cont. Operations ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter January - 174.24 % -56.58 % 34.51 %
III Quarter October - 2.96 % 101.49 % -54.42 %
II Quarter July - 72.46 % -34.6 % 43.54 %
I Quarter April -16.6 % 6.82 % 56.03 % -13.5 %
FY   - 41.86 % -2.1 % 0.18 %

Financial Statements
Johnson And Johnson's first quarter 2022 EPS from Cont. Operations $ 1.96 JNJ's Income Statement
Johnson And Johnson's first quarter 2021 EPS from Cont. Operations $ 2.35 Quarterly JNJ's Income Statement
New: More JNJ's historic EPS from Cont. Operations Growth >>


JNJ EPS from Cont. Operations (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter January - 30.22 % -51.11 % 126.87 %
III Quarter October - -41.6 % -2.17 % -68.25 %
II Quarter July - 1.28 % -37.27 % 49.65 %
I Quarter April 8.29 % 256.06 % 44.74 % 24.78 %
FY (Year on Year)   - 41.86 % -2.1 % 0.18 %




EPS from Cont. Operations first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #2
Healthcare Sector #23
Overall #374

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
882.92 % 14.86 % -92.23 %
(Dec 30 2018)   (Dec 31 2017)
EPS from Cont. Operations first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #2
Healthcare Sector #23
Overall #374
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
882.92 % 14.86 % -92.23 %
(Dec 30 2018)   (Dec 31 2017)

EPS from Cont. Operations by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Johnson And Johnson's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
1687.5 % 30.46 % -100 %
(March 31, 2012)  


JNJ's I. Quarter Q/Q EPS from Cont. Operations Comment
Johnson and Johnson achieved in the I. Quarter 2022 below company average EPS from Cont. Operations increase of 8.29% quarter on quarter, to $ 1.96 .

Within Major Pharmaceutical Preparations industry 23 other companies have achieved higher EPS from Cont. Operations quarter on quarter growth. While Johnson And Johnson's EPS from Cont. Operations growth quarter on quarter, overall rank is 902.


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #24
Healthcare Sector #57
Overall #902
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #24
Healthcare Sector #57
Overall #902
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
1687.5 % 30.46 % -100 %
(March 31, 2012)  


JNJ's I. Quarter Q/Q EPS from Cont. Operations Comment
Johnson and Johnson achieved in the I. Quarter 2022 below company average EPS from Cont. Operations increase of 8.29% quarter on quarter, to $ 1.96 .

Within Major Pharmaceutical Preparations industry 23 other companies have achieved higher EPS from Cont. Operations quarter on quarter growth. While Johnson And Johnson's EPS from Cont. Operations growth quarter on quarter, overall rank is 902.


Johnson And Johnson's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Apr 03 2022)
12 Months Ending
(Jan 02 2022)
12 Months Ending
(Oct 03 2021)
12 Months Ending
(Jul 04 2021)
12 Months Ending
(Apr 04 2021)
Cumulative EPS from Cont. Operations 12 Months Ending $ 7.54 $ 7.93 $ 6.78 $ 6.74 $ 5.74
Y / Y EPS from Cont. Operations Growth (TTM) 31.35 % 41.85 % 5.06 % 16.74 % -11.74 %
Year on Year EPS from Cont. Operations Growth Overall Ranking # 204 # 835 # 673 # 228 # 390
Seqeuential EPS from Cont. Operations Change (TTM) -4.92 % 16.96 % 0.59 % 17.42 % 2.68 %
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # 374 # 572 # 754 # 839 # 1363




Cumulative EPS from Cont. Operations growth Comment
With the quarterly EPS from Cont. Operations reported in the Apr 03 2022 period, Johnson And Johnson's cumulative twelve months EPS from Cont. Operations were $ 8 , company would post below average annual EPS from Cont. Operations growth of 2.68% year on year, if the fiscal year would end at Apr 03 2022.
A slow-down in the Johnson And Johnson's EPS from Cont. Operations growth from the 1.81% growth in Jan 02 2022. Comparing the results with it's peers in Major Pharmaceutical Preparations industry, Johnson And Johnson's trailing twelve months EPS from Cont. Operations growth, were the second highest.

Among companies within the Healthcare sector 11 other companies have achieved higher trailing twelve month EPS from Cont. Operations growth. While Total ranking has impoved so far to 204, from total ranking in previous quarter at 835.

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
882.92 %
14.86 %
-92.23 %
 

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 2
Healthcare Sector # 12
Overall # 204

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
1139.38 %
69.57 %
-92.48 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 23
S&P 500 # 374
Cumulative EPS from Cont. Operations growth Comment
With the quarterly EPS from Cont. Operations reported in the Apr 03 2022 period, Johnson And Johnson's cumulative twelve months EPS from Cont. Operations were $ 8 , company would post below average annual EPS from Cont. Operations growth of -92.48% year on year, if the fiscal year would end at Apr 03 2022.
A slow-down in the Johnson And Johnson's EPS from Cont. Operations growth from the 1.81% growth in Jan 02 2022. Comparing the results with it's peers in Major Pharmaceutical Preparations industry, Johnson And Johnson's trailing twelve months EPS from Cont. Operations growth, were the second highest.

Among companies within the Healthcare sector 11 other companies have achieved higher trailing twelve month EPS from Cont. Operations growth. While Total ranking has impoved so far to 204, from total ranking in previous quarter at 835.

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
882.92 %
14.86 %
-92.23 %
 


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 2
Healthcare Sector # 12
Overall # 204

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
1139.38 %
69.57 %
-92.48 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 23
S&P 500 # 374




Other EPS from Cont. Operations Growth
Major Pharmaceutical Preparations Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
JNJ's EPS from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for JNJ's Competitors
EPS from Cont. Operations Growth for Johnson And Johnson's Suppliers
EPS from Cont. Operations Growth for JNJ's Customers

You may also want to know
JNJ's Annual Growth Rates JNJ's Profitability Ratios JNJ's Asset Turnover Ratio JNJ's Dividend Growth
JNJ's Roe JNJ's Valuation Ratios JNJ's Financial Strength Ratios JNJ's Dividend Payout Ratio
JNJ's Roa JNJ's Inventory Turnover Ratio JNJ's Growth Rates JNJ's Dividend Comparisons



Companies with similar EPS from Cont. Operations increase for the quarter ending Apr 03 2022 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Apr 03 2022
Envista Holdings Corporation-4.44%$ -4.444 
Masimo Corp-13.40%$ -13.402 
Johnson and Johnson-16.60%$ -16.596 
National Vision Holdings Inc -30.19%$ -30.189 
Illumina Inc -45.54%$ -45.545 
Lakeland Industries Inc.-74.14%$ -74.138 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

PORT's Profile

Stock Price

PORT's Financials

Business Description

Fundamentals

Charts & Quotes

PORT's News

Suppliers

PORT's Competitors

Customers & Markets

Economic Indicators

PORT's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071